Literature DB >> 853505

Synthesis and anti-herpes simplex activity of analogues of phosphonoacetic acid.

T R Herrin, J S Fairgrieve, R R Bower, N L Shipkowitz.   

Abstract

The synthesis of monoesters (P and C) of phosphonoacetic acid (PA) is given. The carboxyl esters were prepared by two methods: the reaction of chloroacetates with tris(trimethylsilyl) phosphite, followed by hydrolysis; and by the acid-catalyzed esterification of PA with the appropriate alcohol. P-Monoesters of PA were prepared either by the reaction of alkyl[bis(trimethylsilyl)] phosphite with benzyl chloroacetate followed by deprotection or by the reaction of dimethylphenyl phosphite with benzyl bromoacetate followed by hydrogenolysis. Three aryl- (alkyl-)phosphinic acid derivatives are reported. The above compounds were evaluated for anti-herpes activity against HSV-induced DNA polymerase and in animals infected with herpes dermatitis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 853505     DOI: 10.1021/jm00215a008

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate.

Authors:  J M Reno; L F Lee; J A Boezi
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

2.  Phosphonoacyl compounds as inhibitors of viral nucleic acid polymerases.

Authors:  F E Hahn
Journal:  Naturwissenschaften       Date:  1979-04

3.  Structure-activity studies on phosphonoacetate.

Authors:  J C Mao; E R Otis; A M von Esch; T R Herrin; J S Fairgrieve; N L Shipkowitz; R G Duff
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

4.  Increased efficacy of phosphonoformate and phosphonoacetate inhibition of herpes simplex virus type 2 replication by encapsulation in liposomes.

Authors:  F C Szoka; C J Chu
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.